Creative Planning’s Alimera Sciences ALIM Stock Holding History

Creative Planning’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-133	Closed	-$4K	–	4561
2016 Q1	$4K	Buy	+133	New	+$4.14K	﹤0.01%	3727
2014 Q4	–	Sell	-9	Closed	-$1K	–	4383
2014 Q3	$1K	Buy	+9	New	+$769	﹤0.01%	3883
2014 Q2	–	Sell	-7	Closed	-$1K	–	3996
2014 Q1	$1K	Hold	7	–	–	﹤0.01%	3538
2013 Q4	$0	Hold	7	–	–	﹤0.01%	3502
2013 Q3	$0	Hold	7	–	–	﹤0.01%	3383
2013 Q2	$0	Buy	+7	New	+$404	﹤0.01%	3131

Other funds holding ALIM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Scale Management Foster City, California $359M AUM

NRC

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

PVMCI

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Creative Planning's ALIM Position: Q2 2016 in Review

Creative Planning sold out of Alimera Sciences (ALIM) in Q2 2016, closing a stake of 133 shares — an estimated $4K sold.

Creative Planning first reported a position in ALIM in Q2 2013 and held it in 6 quarters. The position peaked at $4K in Q1 2016. 49 funds tracked by Wall St. Rank hold ALIM as of Q2 2016.

Creative Planning reported no remaining Alimera Sciences position as of Q2 2016 after selling out during the quarter.
Creative Planning sold 133 Alimera Sciences shares in Q2 2016, an estimated $4K.
Creative Planning first reported a position in Alimera Sciences in Q2 2013 and held it in 6 quarters.
Creative Planning's Alimera Sciences position peaked at $4K in Q1 2016.
49 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2016.

Based on Creative Planning's 13F filing for Q2 2016, filed 12 Jul 2016.